# China NMPA Product Recall - Biological acetabular cup system

Source: https://www.globalkeysolutions.net/records/china_product_recall/depuy-orthopaedics-inc/1c047677-e3e5-45d7-ba2d-19a75d3536f0/
Source feed: China

> China NMPA product recall for Biological acetabular cup system by DePuy Orthopaedics, Inc. published January 13, 2017. Recall level: . The National Medical Products Administration (NMPA) published a recall notice regarding DePuy Orthop

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: DePuy Orthopaedics, Inc. is recalling its biological acetabular cup system.
- Company Name: DePuy Orthopaedics, Inc.
- Publication Date: 2017-01-13
- Product Name: Biological acetabular cup system
- Recall Reason: The biological acetabular cup system was manufactured by four different companies. Ten biological acetabular cup systems manufactured by a company not registered in Japan were imported into Japan and distributed to hospitals.
- Discovering Company: Johnson & Johnson (Shanghai) Medical Devices Co., Ltd.
- Manufacturing Company: DePuy Orthopaedics, Inc.
- Summary: The National Medical Products Administration (NMPA) published a recall notice regarding DePuy Orthopaedics, Inc.'s Biological Acetabular Cup System. On January 4, 2017, Johnson & Johnson (Shanghai) Medical Devices Co., Ltd., the responsible unit in China, reported a voluntary recall initiated by DePuy Orthopaedics, Inc. The core issue involved 10 units of the product (National Medical Device Registration Certificate No. 20153460710) that were imported into Japan and subsequently distributed to hospitals by a manufacturer not properly registered in Japan. This lapse in regulatory compliance for manufacturing and distribution prompted the recall. While the affected products were distributed solely in Japan, DePuy Orthopaedics, Inc. explicitly stated that none of these specific recalled units were imported or sold in the Chinese market. Consequently, no direct product retrieval or corrective actions are necessary within China regarding these particular batches. Nonetheless, the NMPA, operating under its regulatory framework, mandated that Food and Drug Administrations across all Chinese provinces, autonomous regions, and municipalities strengthen their supervision and management over similar medical devices. This directive serves as a preventative measure to ensure strict adherence to registration requirements and to protect public health by maintaining high standards for medical device integrity in China.

Company: https://www.globalkeysolutions.net/companies/depuy-orthopaedics-inc/abe8ff95-754c-4e38-898b-9df32f104a7a/